Microsatellite Instability Testing
The latest news on microsatellite instability testing.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.
Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer
The assay is intended to detect
Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition
The new consortium is aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the US, to help inform their treatment decisions.
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
NCCN's Updated Inherited Colorectal Cancer Risk Guidelines Features Gene-Specific Information
The updated guidelines now also highlight the use of PCR and next-generation sequencing to determine microsatellite instability
Feb 12, 2020
Dec 17, 2019
Sep 23, 2019
Aug 8, 2019
Feb 28, 2019
Biocartis 2018 Revenues Rise 32 Percent
Jan 18, 2019
Jan 8, 2019